Journal of Clinical Epidemiology
Volume 59, Issue 11 , Pages 1134-1149 , November 2006

Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration

  • Joel J. Gagnier

      Affiliations

    • Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    • Canadian College of Naturopathic Medicine, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author. 5955 Ontario Street, Unit #307, Windsor, Ontario, Canada, N8S1W6. Tel.: +1-519-974-9690; fax: +1-519-258-2396.
    • ,
  • Heather Boon

      Affiliations

    • Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Paula Rochon

      Affiliations

    • Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    • Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    • ,
  • David Moher

      Affiliations

    • Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada
    • Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    • Department of Epidemiology & Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    • ,
  • Joanne Barnes

      Affiliations

    • Centre for Pharmacognosy & Phytotherapy, School of Pharmacy, University of London, London, United Kingdom
    • ,
  • Claire Bombardier

      Affiliations

    • Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    • Institute for Work & Health, Toronto, Ontario, Canada
    • ,
  • for the CONSORT Group

      Affiliations

    • Members of this group are listed in Section 8.

,Accepted 16 December 2005.

References 

  1. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised consort statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663–694
  2. Mulrow CD, Cook DJ, Davidoff F. Systematic reviews: critical links in the great chain of evidence. In:  Mulrow C,  Cook D editor. Systematic reviews: synthesis of best evidence for health-care decisions. ACP: Philadelphia, PA; 1998;
  3. Sackett DL, Richardsom WS, Rosenberg W, Haynes B. Evidence-based medicine: how to practice and teach EBM. New York, NY: Churchill Livingston; 1998;
  4. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–412
  5. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials: current issues and future directions. Int J Technol Assess Health Care. 1996;12:195–208
  6. Jadad AR, Moore A, Carroll D, Jenkinson C, Reynold DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials. 1996;17:1–12
  7. Begg CB, Cho MK, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA. 1996;76:637–639
  8. Moher D, Schulz KF, Altman D for the CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285:1987–1991
  9. The CONSORT Group . Accessed Nov 1, 2004. Available at http://www.consort-statement.org/endorsements/endorsements.htm
  10. Ioannidis JPA, Evans SJW, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, et al. for the CONSORT Group Improving the reporting of harms in randomized trials: expansion of the CONSORT statement. Ann Int Med. 2004;141:781–788
  11. MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R. Standards for Reporting Interventions in Controlled Trials of Acupuncture: The STRICTA Recommendations. Acupunct Med. 2001;20(1):22–25
  12. Linde K, Jonas WB, Melchart D, Willich S. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol. 2001;30:526–531
  13. Moher D, Sampson M, Campbell K, Beckner W, Lepage L, Gaboury I, et al. Assessing the quality of reports of randomized trials in pediatric and complementary and alternative medicine. BMC Pediatrics. 2002;2:
  14. Linde K, ter Riet G, Hondras M, Vickers A, Saller R, Melchart D. Systematic reviews of complementary therapies—an annotated bibliography. Part 2: Herbal medicine. BMC Complement Altern Med. 2001;1:5
  15. Gagnier, JJ, VanTulder, M, Bombardier, C, Burman, B. Botanical medicine for low back pain. Cochrane Review (Protocol Published 2003).
  16. Little C, Parsons T. Herbal therapy for treating rheumatoid arthritis. Cochrane Library. 2000;4:
  17. Gagnier JJ, DeMelo J, Bombardier C. Quality of reports of randomized controlled intervention trials of herbal medicines. Am J Med. 2006;(in press)
  18. Campbell MK, Elbourne DR, Altman DG for the CONSORT Group. CONSORT statement: extension to cluster randomized trials. BMJ. 2004;328:702–708
  19. Gagnier JJ, Boon H, Rochon P, Barnes J, Moher D, Bombardier CB for the CONSORT Group. Reporting randomized controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Int Med. 2006;144:364–367
  20. Mix JA, Crews WD. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 7611 in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol Clin Exp. 2002;17:267–277
  21. Isaacsohn JL, Moser M, Stein EA, Dudley K, Davey K, Liskov E, et al. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Int Med. 1998;158:1189–1194
  22. Murphy LS, Reinsch S, Najm WI, Dickerson VM, Seffinger MA, Adams A, et al. Searching biomedical databases on complementary medicine: the use of controlled vocabulary among authors, indexers and investigators. BMC Complement Altern Med. 2003;3:3
  23. McGregor B. Medical indexing outside the National Library of Medicine. J Me Libr Assoc. 2002;90:339–341
  24. Kronenberg F, Molholt P, Zeng ML, Eskinazi D. A comprehensive information resource on traditional, complementary, and alternative medicine: toward an international collaboration. J Altern Complement Med. 2001;7:723–729
  25. Pietri S, Seguin JR, d'Arbigny P, Drieu K, Culcasi M. Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induces oxidative stress in patients undergoing coronary bypass surgery. Cardiovasc Drugs Ther. 1997;11:121–131
  26. Savulescu J, Chalmer I, Blunt J. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. BMJ. 1996;313:1390–1393
  27. Ho FM, Hunag PJ, Lee FK, Chern TS, Chiu TW, Liau CS. Effect of acupuncture at Nei-Kuan on left ventricular function in patients with coronary artery disease. Am J Chin Med. 1999;27:149–156
  28. Xueping Z, Zhongying Z, Miaowen J, Hong W, Mianhua W, Yaohong S, et al. Clinical study of Qingluo Tongbi Granules in treating 63 patients with rheumatoid arthritis of the type yin-deficiency and heat in the collaterals. J Trad Chin Med. 2004;24(2):83–87
  29. Johnson ES. Feverfew: a traditional remedy for migraine and arthritis. London: Sheldon Press; 1984;
  30. Shelton RC, Keller MB, Gellenberg A, Dunner DL, Hirschfeld R, Thase ME, et al. Effectiveness of St. John's wort in major depression: a randomized controlled trial. JAMA. 2001;285:1978–1986
  31. Roberts C. The implications of variation in outcome between health professionals for the design and analysis of randomized controlled trials. Stat Med. 1999;18:2605–2615
  32. Dreikorn K, Borkowsi A, Braeckman J, Denis L, Ferrari P, Gerber G, et al. Other medical therapies. In:  Denis L,  Griffiths K,  Khoury S,  Cockett ATK,  McConnell J,  Chatelain C,  Murphy G,  Yoshida O editor. Proceedings of the 4th international consultation on benign prostatic hyperplasia (BPH). Plymouth: Plymbridge Distributors; 1998;p. 633–659
  33. Dreikorn K, Lowe F, Borkowski A, Buck C, Braeckman J, Chopin D. Other medical therapies. In: Chatelain ,  Denis L,  Foo KT,  Khoury S,  McConnell J editor. Proceedings of the 5th international consultation on benign prostatic hyperplasia (BPH). Plymouth: Plymbridge Distributors; 2001;p. 479–511
  34. Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial Ginseng products: an analysis of 25 preparations. Am J Clin Nutr. 2002;75:600–601
  35. Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm. 2000;57:963–969
  36. Liberti LE, Der Marderosian A. Evaluation of commercial ginseng products. J Pharm Sci. 1978;67:1487–1489
  37. Groenewegen WA, Heptinstall S. Amounts of feverfew in commercial preparations of the herb. Lancet. 1986;1:44–45
  38. Heptinstall S, Awang DV, Dawson BA, Kindack D, Knight DW, May J, et al. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium [L.] Schultz-Bip.). Estimation of commercial and authenticated feverfew products. J Pharm Pharmacol. 1992;44:391–395
  39. Nelson MH, Cobb SE, Shelton J. Variations in parthenolide content and daily dose of feverfew products. Am J Health Syst Pharm. 2002;59:1527–1531
  40. Zhang H, Yu C, Jia JY, Leung SW, Siow YL, Man RY, et al. Contents of four active components in different commercial crude drugs and preparations of danshen (Salvia miltiorrhiza). Acta Pharmacol Sin. 2002;23:1163–1168
  41. Manning J, Roberts JC. Analysis of catechin content of commercial green tea products. J Herb Pharmacother. 2003;3(3):19–32
  42. Schulte-Lobbert S, Holloubek G, Muller WE, Schubert-Zsilavecz M, Wurglics M. Comparison of the synaptosomal uptake inhibition of serotonin by St. John's wort products. J Pharm Pharmacol. 2004;56:813–818
  43. Garrara J, Hamrs S, Eberly LE, Matiak A. Variations in product choices of frequently purchased herbs: caveat emptor. Arch Int Med. 2003;163:2290–2295
  44. Weber HA, MK Zart, Hodges AE, Molloy HM, O'Brien BM, Moody LA, et al. Chemical comparison of goldenseal (Hydrastis canadensis L.) root powder from three commercial suppliers. J Agric Food Chem. 2003;51:7352–7358
  45. Carlson M, Thompson RD. Liquid chromatographic determination of methylzanthines and catechins in herbal preparations containing guarana. J AOAC Int. 1998;81:691–701
  46. Lefebvre T, Foster BC, Drouin CE, Krantis A, Livesy JF, Jordan SA. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J Pharm Pharm Sci. 2004;7:265–273
  47. Oberlies NH, Kim NC, Brine DR, Collins BJ, Handy RW, Sparacino CM, et al. Analysis of herbal teas made from the leaves of comfrey (Symphytum officinale): reduction of N-oxides results in order of magnitude increases in the measurable concentration of pyrrolizidine alkaloids. Public Health Nutr. 2004;7:919–924
  48. Haller CA, Duan M, Benowitz Nl, Jacob P. Concentrations of Ephedra alkaloids and caffeine in commercial dietary supplements. J Anal Toxicol. 2004;28:145–151
  49. Sievenpiper JL, Arnason JT, Leiter LA, Vuksan V. Variable effects of American ginseng: a batch of American ginseng (Panax quinquefolius L.) with a depressed ginsenoside profile does not affects postprandial glycemia. Eur J Clin Nutr. 2003;57:243–248
  50. Greuter W, Mcneill J, Barrie FR, Burdet HM, Demoulin V, Filgueiras TS, et al. International Code of Botanical Nomenclature (ST LOUIS CODE), adopted by the Sixteenth International Botanical Congress, St Louis, Missouri, July 1999. Available at http://www.bgbm.fu-berlin.de/iapt/nomenclature/code/SaintLouis/0000St.Luistitle.htm (Accessed July 2004).
  51. Pellati F, Benvenuti S, Margro L, Melegari M, Soragni F. Analysis of phenolic compounds and radical scavenging activity of Echinacea spp. J Pharm Biomed Anal. 2004;35:289–301
  52. Vuksan V, Sivenpiper JL, Wong J, Xu Z, Beljan-Zdravkovic U, Arnason JT, et al. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose dependent manner in healthy individuals. Am J Clin Nutr. 2001;73:753–758
  53. Morgenstern C, Biermann E. The efficacy of Ginkgo special extract Egb 761 in patients with tinnitus. Int J Clin Pharmacol Ther. 2003;5:188–197
  54. Betz JM, Eppley RM, Taylor WC, Andrzejewski D. Determination of pyrrolizidine alkaloids in commercial comfrey products (Symphytum sp.). J Pharm Sci. 1994;83:649–653
  55. Patora J, Majda T, Gora J, Klimek B. Variability in the content and composition of essential oil from lemon balm (Melissa officinalis L.) cultivated in Poland. Acta Pol Pharm. 2003;60(5):395–400
  56. Drew S, Davies E. Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ. 2001;322:1–6
  57. Vuksan V, Starva MP, Sivenpiper JL, Koo VYY, Wong E, Beljan-Zdravkovic U, et al. American Ginseng improves glycemia in individuals with normal glucose tolerance: effect of dose and time escalation. J Am Coll Nutr. 2000;19:738–744
  58. Swanson CA. Suggested guidelines for articles about botanical dietary supplements. Am J Clin Nutr. 2002;75:8–10
  59. Instructions to authors. Phytomed Int J Phytother Phytopharmacol. Available at http://www.elsevier.de/artikel/805109&_text=&_text=autorenhinweise (accessed July 2004).
  60. German Federal Institute for Drugs and Medical Device . The complete German Commission E monographs: therapeutic guide to herbal medicines. Boston, MA: Integrative Medicine Communications; 1999;
  61. Bauer R, Tittel G. Quality assessment of herbal preparations as a precondition of pharmacological and clinical studies. Phytomedicine 2000;26;2(3):193–8.
  62. Association of Analytical Communities (AOAC) . Accessed Nov 1, 2004. Available at http://www.aoac.org/
  63. American Herbal Pharmacopoeia. Accessed Nov 1, 2004. Available at http://www.herbal-ahp.org/order_online.htm
  64. United States Pharmacopoeia. Accessed Nov 3, 2004. Available at http://www.uspverified.org/resourcerequestform_man.html
  65. Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere. 2003;52:1361–1371
  66. Murphy JJ, Heptinstall S, Mitchell JRA. Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet. 1988;2(8604):189–192
  67. Vickers AJ, de Craen AJM. Why use placebos in clinical trials? A narrative review of the methodological literature. J Clin Epidemiol. 2000;53:157–161
  68. Palevitch D, Earon G, Carasso R. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytother Res. 1997;11:508–511
  69. Brinkhaus B, Hummelsberger J, Kohnen R, Seufert J, Hempen CH, Leonhardy H, et al. Acupuncture and Chinese herbal medicine in the treatment of patients with seasonal allergic rhinitis: a randomized-controlled clinical trial. Allergy. 2004;59:953–960
  70. Bent S, Xu L, Lui L, Nevitt M, Schneider E, Tian G, et al. A randomized controlled trial of a Chinese herbal remedy to increase energy, memory, sexual function and quality of life in elderly adults in Beijing, China. Am J Med. 2003;115:441–447
  71. Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. BMJ. 1985;291:569–573
  72. Piscitelli SC, Burstein AH. Herb-drug interactions and confounding in clinical trials. J Herb Pharmacother. 2002;2:23–26
  73. Pietri S, Seguin JR, d'Arbigny P, Drieu K, Culcasi M. Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery. Cardiovasc Drugs Ther. 1997;11:121–131
  74. Dowling EA, Redondo DR, Branch JD, Jones S, McNabb G, Williams MH. Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance. Med Sci Sports Exerc. 1996;28:482–489
  75. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials. Philidelphia, PA: Lippincott; 1996;
  76. Gardner CD, Chatterjee LM, Carlson JJ. The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults. Atherosclerosis. 2001;154:213–220
  77. Annals of Internal Medicine. Information for authors. Accessed January 10, 2001. Available at http://www.annals.org/

PII: S0895-4356(06)00250-2

doi: 10.1016/j.jclinepi.2005.12.020

Journal of Clinical Epidemiology
Volume 59, Issue 11 , Pages 1134-1149 , November 2006

Article Tools